Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 431

1.

[123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].

Padberg BC, Rordorf T, Suter SL, Pfeiffer D, Wild D, Schröder S.

Pathologe. 2007 Jul;28(4):281-4. German.

PMID:
16673076
2.

False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan.

Letizia C, De Toma G, Massa R, Corsi A, Caliumi C, Subioli S, D'Erasmo E.

J Endocrinol Invest. 1998 Dec;21(11):779-83.

PMID:
9972680
3.

Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.

Nakatani T, Hayama T, Uchida J, Nakamura K, Takemoto Y, Sugimura K.

Oncol Rep. 2002 Nov-Dec;9(6):1225-7.

PMID:
12375024
4.

Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review.

Sone H, Okuda Y, Nakamura Y, Ishikawa N, Yamaoka T, Kawakami Y, Odawara M, Matsushima T, Kawai K, Yamashita K.

Horm Res. 1996;46(3):138-42. Review.

PMID:
8894669
5.

Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.

Furuta N, Kiyota H, Yoshigoe F, Hasegawa N, Ohishi Y.

Int J Urol. 1999 Mar;6(3):119-24.

6.
7.
8.

Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.

Campeau RJ, Garcia OM, Correa OA, Rege AB.

South Med J. 1991 Oct;84(10):1221-30. Review.

PMID:
1925724
9.

A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.

Cecchin D, Lumachi F, Marzola MC, Opocher G, Scaroni C, Zucchetta P, Mantero F, Bui F.

Endocr Relat Cancer. 2006 Jun;13(2):525-33.

11.

Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.

Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, Parmentier C.

J Nucl Med. 1995 Jan;36(1):1-6.

12.

[The efficacy of early 123I-MIBG scintigraphy for pheochromocytoma diagnosis].

Ishikawa N, Takeda T, Wu J, Echigo J, Itai Y.

Kaku Igaku. 1995 Jul;32(7):659-65. Japanese.

PMID:
7674577
13.

Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.

Lev I, Kelekar G, Waxman A, Yu R.

Endocr Pract. 2010 May-Jun;16(3):398-407. doi: 10.4158/EP09302.OR.

PMID:
20061293
14.

Meta-iodobenzylguanidine in children.

Gelfand MJ.

Semin Nucl Med. 1993 Jul;23(3):231-42. Review.

PMID:
8378796
15.

Current concepts on the diagnostic use of MIBG in children.

Shulkin BL, Shapiro B.

J Nucl Med. 1998 Apr;39(4):679-88.

16.

Quantitation of iodine-123 MIBG uptake by normal adrenal medulla in hypertensive patients.

Bomanji J, Flatman WD, Horne T, Fettich J, Britton KE, Ross G, Besser GM.

J Nucl Med. 1987 Mar;28(3):319-24.

17.

Iodine-131-MIBG scintigraphy in adults: interpretation revisited?

Roelants V, Goulios C, Beckers C, Jamar F.

J Nucl Med. 1998 Jun;39(6):1007-12.

18.

Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.

Shulkin BL, Shapiro B, Tobes MC, Shen SW, Wieland DM, Meyers LJ, Lee HT, Petry NA, Sisson JC, Beierwaltes WH.

J Nucl Med. 1986 Jul;27(7):1138-42.

19.

Thallium-201 scintigraphy in the diagnosis of pheochromocytoma.

Wenisch HJ, Maul FD, Happ J, Schumm PM, Bittner G, Wanner U, Hör G, Encke A.

Cardiology. 1985;72 Suppl 1:150-2.

PMID:
4053122
20.

Localization of a pheochromocytoma using I-123 MIBG adrenal scintigraphy.

Shirkare S, Kuwert T, Weckesser M, Czech N, Langen KJ, Muller-Gartner HW.

J Postgrad Med. 1994 Apr-Jun;40(2):85-7.

Items per page

Supplemental Content

Write to the Help Desk